Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.51 CHF | +0.53% | -3.96% | -3.57% |
08:22am | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
07:00am | Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.57% | 95.38M | |
+5.73% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+27.76% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera to File Rolling New Drug Application for Duchenne Treatment to US FDA in Early 2022